1 |
BONSER L R, ERLE D J. Airway mucus and asthma: The role of MUC5AC and MUC5B[J]. J Clin Med,2017, 6(12): 112.
|
2 |
MIMS J W. Asthma: definitions and pathophysiology[J]. Int Forum Allergy Rhinol, 2015,5 (): S2-S6.
|
3 |
SOCKRIDER M, FUSSNER L. What is asthma?[J]. Am J Respir Crit Care Med, 2020, 202(9):25-26.
|
4 |
NAM H H, LEE J H, RYU S M, et al. Gekko gecko extract attenuates airway inflammation and mucus hypersecretion in a murine model of ovalbumin-induced asthma[J]. J Ethnopharmacol, 2022, 282: 114574.
|
5 |
PAPADOPOULOS N G, MILIGKOS M, XEPAPADAKI P. A current perspective of allergic asthma: From mechanisms to management[J]. Handb Exp Pharmacol, 2022, 268: 69-93.
|
6 |
DING F, LIU B, ZOU W, et al. LPS exposure in early life protects against mucus hypersecretion in ovalbumin-induced asthma by down-regulation of the IL-13 and JAK-STAT6 pathways[J]. Cell Physiol Biochem, 2018, 46(3): 1263-1274.
|
7 |
LIU H, WU X, LUO J, et al. Pterostilbene attenuates astrocytic inflammation and neuronal oxidative injury after ischemia-reperfusion by inhibiting NF-κB phosphorylation[J]. Front Immunol, 2019,10: 2408.
|
8 |
JIANG Z Y, MENG Y, BO L L,et al. Sophocarpine attenuates LPS-induced liver injury and improves survival of mice through suppressing oxidative stress, inflammation, and apoptosis[J]. Mediators Inflamm, 2018, 2018: 5871431.
|
9 |
ZHI W, DU X, LI Y, et al. Proteome profiling reveals the efficacy and targets of sophocarpine against asthma[J]. Int Immunopharmacol, 2021,96: 107348.
|
10 |
CHEN L, XU J, DENG M, et al. Telmisartan mitigates lipopolysaccharide (LPS)-induced production of mucin 5AC (MUC5AC) through increasing suppressor of cytokine signaling 1 (SOCS1)[J]. Bioengineered, 2021,12(1): 3912-3923.
|
11 |
SUNG Y Y, KIM S H, YUK H J, et al. Siraitia grosvenorii residual extract attenuates ovalbumin-induced lung inflammation by down-regulating IL-4, IL-5, IL-13, IL-17, and MUC5AC expression in mice[J]. Phytomedicine, 2019, 61: 152835.
|
12 |
黄帅阳,崔红生,候丹,等. PNEC-ILC2神经免疫通路在支气管哮喘中的研究进展[J]. 实用医学杂志, 2022, 38(1): 120-124.
|
13 |
CHEN X, YANG J, SHEN H, et al. Muc5ac production inhibited by decreased lncRNA H19 via PI3K/Akt/NF-kB in asthma[J]. J Asthma Allergy, 2021, 14: 1033-1043.
|
14 |
GANS M D, GAVRILOVA T. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes[J]. Paediatr Respir Rev,2020, 36: 118-127.
|
15 |
MA L, CHANG E, RUAN X, et al. The protective effects of Omarigliptin against Lipopolysaccharide (LPS)- induced inflammatory response and expression of mucin 5AC (MUC5AC) in human bronchial epithelial cells[J]. Mol Immunol, 2022, 141: 108-115.
|
16 |
杨梦, 张伟, 李强, 等. 低氧对人气道上皮细胞NCI-H292黏液合成的影响[J]. 西部医学, 2016, 28(5): 615-620,624.
|
17 |
SONG W Y, SONG Y S, RYU H W, et al. Tilianin inhibits MUC5AC expression mediated via down-regulation of EGFR-MEK-ERK-Sp1 signaling pathway in NCI-H292 human airway cells[J]. J Microbiol Biotechnol, 2017,27(1): 49-56.
|
18 |
LEE G H, JIN S W, CHOI J H, et al. Influence of o,p'-DDT on MUC5AC expression via regulation of NF-κB/AP-1 activation in human lung epithelial cells[J]. J Toxicol Environ Health A, 2021, 84(20): 836-845.
|
19 |
朱林筠,孙亦鹏,王雄彪. 中药抗哮喘气道炎症机制的研究进展[J]. 上海中医药杂志,2021, 55(3): 98-104.
|
20 |
DONG Y, ZHANG X, YAO C, et al. Atractylodin attenuates the expression of MUC5AC and extracellular matrix in lipopolysaccharide-induced airway inflammation by inhibiting the NF-κB pathway[J]. Environ Toxicol, 2021, 36(9): 1911-1922.
|
21 |
XUE K, RUAN L, HU J, et al. Panax notoginseng saponin R1 modulates TNF-α/NF-κB signaling and attenuates allergic airway inflammation in asthma[J]. Int Immunopharmacol, 2020, 88: 106860.
|
22 |
KIM Y D, ChOI Y S, NA H G, et al. Ginsenoside Rb1 attenuates LPS-induced MUC5AC expression via the TLR4-mediated ERK1/2 and NF-κB pathway in human airway epithelial NCI-H292 cells[J]. J Biol Regul Homeost Agents, 2020, 34(2): 613-618.
|
23 |
SHI X, WANG S, LUAN H, et al. Clinopodium chinense attenuates palmitic acid-induced vascular endothelial inflammation and insulin resistance through TLR4-Mediated NF-κB and MAPK pathways[J]. Am J Chin Med, 2019,47(1): 97-117.
|
24 |
PAN H H, HSIAO Y P, CHEN P J, et al. Epithelial growth factor receptor tyrosine kinase inhibitors alleviate house dust mite allergen Der p2-induced IL-6 and IL-8[J]. Environ Toxicol, 2019, 34(4): 476-485.
|
25 |
ZHANG R G, NIU Y, PAN K W, et al. β2-adrenoceptor activation stimulates IL-6 production via PKA, ERK1/2, Src, and Beta-arrestin2 signaling pathways in human bronchial epithelia[J]. Lung,2021,199(6): 619-627.
|
26 |
SHUKUR W, ALYAQUBI K, DOSH R, et al. Association of Toll-like receptors 4 (TLR-4) gene expression and polymorphisms in patients with severe asthma[J]. J Med Life, 2021, 14(4): 544-548.
|
27 |
WU Z, MEHRABI NASAB E, ARORA P, et al. Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4/NF-κB signaling pathway[J]. J Transl Med, 2022, 20(1): 130.
|
28 |
万浩宇,张璐,万海同,等. 基于p38MAPK/NF-κB信号通路的麻黄汤抗哮喘作用机制研究[J]. 中国药理学通报,2021,37(3): 423-429.
|